05:42 PM EDT, 04/10/2024 (MT Newswires) -- Richard E Lowenthal, 10% Owner, Director, President and CEO, on April 09, 2024, sold 100,000 shares in Ars Pharmaceuticals ( SPRY ) for $927,735. Following the Form 4 filing with the SEC, Lowenthal has control over a total of 10,999,622 shares of the company, with 4,126,822 shares held directly and 6,872,800 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1671858/000141588924010659/xslF345X03/form4-04102024_090447.xml